SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-080842
Filing Date
2023-09-29
Accepted
2023-09-29 11:43:01
Documents
115
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2023_inmedpharma.htm   iXBRL 10-K 1639075
2 DESCRIPTION OF SECURITIES OF INMED PHARMACEUTICALS INC f10k2023ex4-13_inmedpharma.htm EX-4.13 7578
3 CONSULTING AGREEMENT DATED AS OF APRIL 1, 2022, BETWEEN INMED PHARMACEUTICALS IN f10k2023ex10-13_inmedpharma.htm EX-10.13 48930
4 SUBSIDIARIES OF THE COMPANY f10k2023ex21-1_inmedpharma.htm EX-21.1 3094
5 CONSENT OF MARCUM LLP f10k2023ex23-1_inmedpharma.htm EX-23.1 2222
6 CONSENT OF KPMG LLP f10k2023ex23-2_inmedpharma.htm EX-23.2 2811
7 CERTIFICATION f10k2023ex31-1_inmedpharma.htm EX-31.1 11923
8 CERTIFICATION f10k2023ex31-2_inmedpharma.htm EX-31.2 11606
9 CERTIFICATION f10k2023ex32-1_inmedpharma.htm EX-32.1 3601
10 CERTIFICATION f10k2023ex32-2_inmedpharma.htm EX-32.2 3350
11 GRAPHIC image_001.jpg GRAPHIC 26093
12 GRAPHIC image_002.jpg GRAPHIC 35382
13 GRAPHIC image_003.jpg GRAPHIC 21093
14 GRAPHIC image_004.jpg GRAPHIC 3603
15 GRAPHIC image_005.jpg GRAPHIC 45207
16 GRAPHIC image_006.jpg GRAPHIC 25275
17 GRAPHIC image_007.jpg GRAPHIC 23410
18 GRAPHIC image_008.jpg GRAPHIC 8052
19 GRAPHIC image_009.jpg GRAPHIC 16971
20 GRAPHIC image_010.jpg GRAPHIC 6464
21 GRAPHIC image_011.jpg GRAPHIC 5896
22 GRAPHIC image_012.jpg GRAPHIC 8774
23 GRAPHIC image_013.jpg GRAPHIC 5451
24 GRAPHIC image_014.jpg GRAPHIC 12773
25 GRAPHIC image_015.jpg GRAPHIC 10534
26 GRAPHIC image_016.jpg GRAPHIC 4380
27 GRAPHIC image_017.jpg GRAPHIC 5550
28 GRAPHIC image_018.jpg GRAPHIC 6812
29 GRAPHIC image_019.jpg GRAPHIC 5562
30 GRAPHIC image_020.jpg GRAPHIC 6171
31 GRAPHIC image_021.jpg GRAPHIC 5366
32 GRAPHIC image_022.jpg GRAPHIC 5331
33 GRAPHIC image_023.jpg GRAPHIC 9946
34 GRAPHIC image_024.jpg GRAPHIC 19487
35 GRAPHIC image_025.jpg GRAPHIC 4178
  Complete submission text file 0001213900-23-080842.txt   8002738

Data Files

Seq Description Document Type Size
36 XBRL SCHEMA FILE inm-20230630.xsd EX-101.SCH 70557
37 XBRL CALCULATION FILE inm-20230630_cal.xml EX-101.CAL 51959
38 XBRL DEFINITION FILE inm-20230630_def.xml EX-101.DEF 307225
39 XBRL LABEL FILE inm-20230630_lab.xml EX-101.LAB 626404
40 XBRL PRESENTATION FILE inm-20230630_pre.xml EX-101.PRE 325881
109 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023_inmedpharma_htm.xml XML 746929
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-39685 | Film No.: 231293267
SIC: 2834 Pharmaceutical Preparations